BayMark provides a nationwide continuum of substance use disorder treatment that combines medication‑assisted therapy (methadone, buprenorphine, naltrexone) with clinical counseling, peer support, and case management. Its services include opioid treatment programs, outpatient Suboxone clinics, hospital‑based detox, and residential programs, all delivered through an integrated network of locations across the U.S. and Canada to ensure coordinated, evidence‑based care for individuals and partner health systems.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals with opioid use disorder and other substance use disorders often lack access to comprehensive, evidence‑based treatment that combines medication, counseling, and ongoing recovery support, leading to high rates of relapse, continued illicit use, and adverse health outcomes.
Solution
BayMark Health Services delivers a nationwide continuum of care that integrates medication‑assisted treatment (MAT) with clinical counseling, peer support, and case management. The company operates Opioid Treatment Programs (OTPs) offering methadone, buprenorphine (Suboxone) and naltrexone, as well as outpatient Suboxone (OBOT) clinics that provide prescription‑based medication and flexible scheduling. In addition, BayMark partners with hospitals to run inpatient withdrawal management (detox) services and runs residential treatment centers that combine medical detox, medication‑assisted therapy, and therapeutic programming. All services are supported by evidence‑based protocols, medical supervision, and coordinated discharge planning to ensure continuity of care across settings.
Target Audience
Primary customers are individuals seeking treatment for opioid use disorder or other substance use disorders, including pregnant patients, as well as hospitals and health systems that partner with BayMark to provide inpatient detox and recovery services.
Features
- OTPs delivering methadone, buprenorphine, and naltrexone with on‑site counseling and peer‑support groups
- Outpatient Suboxone (OBOT) clinics offering prescription‑filled buprenorphine, flexible visit times, telemedicine, and lab services
- Hospital‑based inpatient withdrawal management (New Vision) providing medical stabilization, pre‑screening, and discharge planning under a management contract
- Residential addiction treatment programs with 24‑hour care, individualized treatment plans, and transitional services such as partial hospitalization and intensive outpatient programs
- Integrated case management, referral to community resources, and coordinated treatment for pregnant patients
- Nationwide network of treatment locations across the United States and Canada, enabling patients to access services close to home
- Evidence‑based clinical protocols and continuous outcome monitoring to support long‑term recovery